(A) Representative diagram of vaccination strategy for therapeutic model. (B) Growth curve of B16-F10 tumor. (C) Kaplan-Meier survival curve of B16-F10 tumor-burdened mice. (D) Growth curve of LLC tumor. (E) Kaplan-Meier survival curve of LLC tumor-burdened mice. * indicates for PPP<0.001. Data show mean ± SD of five mice. Data are representative of two independent experiments with similar results.</p
<p>(A) Imputed median primary tumor volumes (mm<sup>3</sup>) for each group, showing significantly s...
<p>A/J mice were inoculated with 1 × 10<sup>6</sup> wild-type (WT) N2a, and once tumors were establi...
<p>5x10<sup>4</sup> B16 tumor cells were injected either intradermally into the flank <b>(A-D)</b> o...
For prophylactic analysis: (A) Representative diagram of vaccination strategy for prophylactic model...
<p>(A, B) The preventive effect of B16-mBD2 vaccination on the development of tumors. Groups of C57B...
Following immunization with differently pulsed BMDCs, splenocytes were analyzed. (A) IFN-γ ELISPOT w...
<p>Mice were injected s.c. with B16 cells on day 0. Mice were immunized s.c. with 1x10<sup>6</sup> D...
<p>(A) Schematic diagram depicting the regimen. On Day 1, TC-1 cells were injected subcutaneously. F...
<p>C57BL/6 mice were vaccinated with untreated B16F10 cells ; mIFN-γ (50 IU/mL); GGTI-298 (10 µM); o...
<p>C57BL/6J (WT) and FtDKO mice were vaccinated intravenously with LM-OVA and challenged with B16-OV...
<p>C57BL/6 mice were immunized with PBS, OVA, fucoidan or OVA + fucoidan on days 0, 15 and 30. On da...
<p><b>A.</b> Diagram illustrating the culture and priming of WT and STAT3 knockout GM-CSF derived BM...
<p>Mice (n = 5) were immunized with various DNA vaccines (mp53, CD40L, or mp53/CD40L) three times at...
The weakly immunogenic murine P1A Ag is a useful experimental model for the development of new vacci...
<p>(A and B) Protection against pre-injected tumors. Four hours after lethal CT26 tumor cell challen...
<p>(A) Imputed median primary tumor volumes (mm<sup>3</sup>) for each group, showing significantly s...
<p>A/J mice were inoculated with 1 × 10<sup>6</sup> wild-type (WT) N2a, and once tumors were establi...
<p>5x10<sup>4</sup> B16 tumor cells were injected either intradermally into the flank <b>(A-D)</b> o...
For prophylactic analysis: (A) Representative diagram of vaccination strategy for prophylactic model...
<p>(A, B) The preventive effect of B16-mBD2 vaccination on the development of tumors. Groups of C57B...
Following immunization with differently pulsed BMDCs, splenocytes were analyzed. (A) IFN-γ ELISPOT w...
<p>Mice were injected s.c. with B16 cells on day 0. Mice were immunized s.c. with 1x10<sup>6</sup> D...
<p>(A) Schematic diagram depicting the regimen. On Day 1, TC-1 cells were injected subcutaneously. F...
<p>C57BL/6 mice were vaccinated with untreated B16F10 cells ; mIFN-γ (50 IU/mL); GGTI-298 (10 µM); o...
<p>C57BL/6J (WT) and FtDKO mice were vaccinated intravenously with LM-OVA and challenged with B16-OV...
<p>C57BL/6 mice were immunized with PBS, OVA, fucoidan or OVA + fucoidan on days 0, 15 and 30. On da...
<p><b>A.</b> Diagram illustrating the culture and priming of WT and STAT3 knockout GM-CSF derived BM...
<p>Mice (n = 5) were immunized with various DNA vaccines (mp53, CD40L, or mp53/CD40L) three times at...
The weakly immunogenic murine P1A Ag is a useful experimental model for the development of new vacci...
<p>(A and B) Protection against pre-injected tumors. Four hours after lethal CT26 tumor cell challen...
<p>(A) Imputed median primary tumor volumes (mm<sup>3</sup>) for each group, showing significantly s...
<p>A/J mice were inoculated with 1 × 10<sup>6</sup> wild-type (WT) N2a, and once tumors were establi...
<p>5x10<sup>4</sup> B16 tumor cells were injected either intradermally into the flank <b>(A-D)</b> o...